<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39392555</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1435-4373</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>11</Day></PubDate></JournalIssue><Title>European journal of clinical microbiology &amp; infectious diseases : official publication of the European Society of Clinical Microbiology</Title><ISOAbbreviation>Eur J Clin Microbiol Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Comparison of clinical and laboratory characteristics of COVID-19 and influenza in hospitalized children.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10096-024-04964-y</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">COVID-19 and influenza infections have similar modes of transmission and clinical symptoms but have different prognoses and treatment methods; therefore, it is important to make a final diagnosis. Herein, we aimed to compare the demographic, clinical, and laboratory differences in hospitalized pediatric patients with COVID-19 and influenza.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective study comprised patients with COVID-19 managed between March 2020 to February 2022, and patients with influenza managed between December 2017 to February 2022, at a tertiary care hospital. The clinical data and laboratory parameters were obtained from the medical records of the hospital. Pediatric intensive care unit (PICU) admission, need for oxygen support, and the mortality rates of the patients were recorded and compared statistically.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall, 107 patients with COVID-19 and 250 patients with influenza were included. Underlying chronic disease (UCD) rates were statistically higher in patients with COVID-19 (p &lt; 0.001). When the symptoms were compared, fever, cough, and runny nose were more common in patients with influenza, and abdominal pain and rash were more common in patients with COVID-19 (p &lt; 0.05). In patients with influenza, white blood cell count and absolute neutrophil count values were lower (p = 0.021 and p = 0.037, respectively), and aspartate aminotransferase and creatinine kinase values were higher (p = 0.007 and p &lt; 0.001, respectively). PICU admission rates and oxygen support needs were similar in both groups (p &gt; 0.05). When the virus was COVID-19, it had 7.8 times higher risk of mortality compared to influenza (p = 0.002). There were statistically significant risk for mortality when the virus was COVID-19, the risk of mortality was 6.9 times higher in those with UCD, 8.5 times higher in those with admission to PICU and 3.8 times higher in those with needing mechanical ventilation (MV) compared to when the virus was influenza (p = 0.004, p = 0.006 and p = 0.049, respectively). The mortality rate was higher in patients with COVID-19 (p = 0.007).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study showed that COVID-19 might negatively affect the survival times and increase mortality rates, especially in children with an UCD, admitted to the PICU and in need of MV.</AbstractText><CopyrightInformation>© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Savaş Şen</LastName><ForeName>Zeynep</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0003-4671-6082</Identifier><AffiliationInfo><Affiliation>Department of Pediatric Infectious Disease, Ankara Etlik Integrated Health Campus, Ankara, 06170, Turkey. zeysa81@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aydın Teke</LastName><ForeName>Türkan</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-5127-4720</Identifier><AffiliationInfo><Affiliation>Department of Pediatric Infectious Disease, Ankara Etlik Integrated Health Campus, Ankara, 06170, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yalcinkaya</LastName><ForeName>Rumeysa</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-0083-0587</Identifier><AffiliationInfo><Affiliation>Department of Pediatric Infectious Disease, Ankara Etlik Integrated Health Campus, Ankara, 06170, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Özdem</LastName><ForeName>Suna</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-8042-9119</Identifier><AffiliationInfo><Affiliation>Department of Pediatric Infectious Disease, Mersin City Hospital, Mersin, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gümüşer Cinni</LastName><ForeName>Rüveyda</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-6373-2589</Identifier><AffiliationInfo><Affiliation>Department of Pediatric Infectious Disease, Ankara Etlik Integrated Health Campus, Ankara, 06170, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Çinar</LastName><ForeName>Hasibe Gökçe</ForeName><Initials>HG</Initials><Identifier Source="ORCID">0000-0003-2687-1544</Identifier><AffiliationInfo><Affiliation>Department of Pediatric Radiology, Ankara Etlik Integrated Health Campus, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Öztürk</LastName><ForeName>Zeynelabidin</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0001-8548-4144</Identifier><AffiliationInfo><Affiliation>Division of Pediatric Intensive Care, Ankara Etlik Integrated Health Campus, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Özdemir</LastName><ForeName>Göktuğ</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-1057-1531</Identifier><AffiliationInfo><Affiliation>Division of Pediatric Intensive Care, Ankara Etlik Integrated Health Campus, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akçaboy</LastName><ForeName>Meltem</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0862-3961</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Ankara Etlik Integrated Health Campus, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polat</LastName><ForeName>Meltem</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Department of Pediatric Infectious Disease, Gazi University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaman</LastName><ForeName>Ayşe</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatric Infectious Disease, Ankara Etlik Integrated Health Campus, Ankara, 06170, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Öz</LastName><ForeName>Fatma Nur</ForeName><Initials>FN</Initials><Identifier Source="ORCID">0000-0001-8374-095X</Identifier><AffiliationInfo><Affiliation>Department of Pediatric Infectious Disease, Ankara Etlik Integrated Health Campus, Ankara, 06170, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Clin Microbiol Infect Dis</MedlineTA><NlmUniqueID>8804297</NlmUniqueID><ISSNLinking>0934-9723</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Children</Keyword><Keyword MajorTopicYN="N">Hospitalized</Keyword><Keyword MajorTopicYN="N">Influenza</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>12</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>12</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>11</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39392555</ArticleId><ArticleId IdType="doi">10.1007/s10096-024-04964-y</ArticleId><ArticleId IdType="pii">10.1007/s10096-024-04964-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization (WHO) Coronavirus (COVID-19) Dashboard (2024) https://data.who.int/dashboards/covid19/cases . Accessed 14 April 2024</Citation></Reference><Reference><Citation>Tasar S, Karadag-Oncel E, Yilmaz-Ciftdogan D et al (2022) Influenza is more severe than our newest enemy (COVID-19) in hospitalized children: experience from a Tertiary Center. J Med Virol 94(9):4107–4114</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27817</ArticleId><ArticleId IdType="pubmed">35477866</ArticleId><ArticleId IdType="pmc">9088615</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention, COVID Data Tracker (2024) https://covid.cdc.gov/covid-data-tracker/#pediatric-data . CDC. Accessed 15 April 2024</Citation></Reference><Reference><Citation>Liu BM, Martins TB, Peterson LK, Hill HR (2021) Clinical significance of measuring serum cytokine levels as inflammatory biomarkers in adult and pediatric COVID-19 cases: a review. Cytokine 142:155478</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2021.155478</ArticleId><ArticleId IdType="pubmed">33667962</ArticleId><ArticleId IdType="pmc">7901304</ArticleId></ArticleIdList></Reference><Reference><Citation>Song X, Delaney M, Shah RK et al (2020) Comparison of clinical features of COVID-19 vs Seasonal Influenza A and B in US children. JAMA Netw Open 3(9):e2020495</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.20495</ArticleId><ArticleId IdType="pubmed">32897374</ArticleId><ArticleId IdType="pmc">7489826</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (2022) Influenza: People at higher risk of flu complications. cdc.gov/flu/highrisk/index.htm . Accessed 2 September 2022</Citation></Reference><Reference><Citation>Shimol AB, Dahan S, Alon N et al (2021) Can laboratory evaluation differentiate between coronavirus disease-2019, influenza, and respiratory syncytial virus infections? A retrospective cohort study. Croat Med J 6:623–629</Citation><ArticleIdList><ArticleId IdType="doi">10.3325/cmj.2021.62.623</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon DA, Sherman AC, Kanjilal S (2020) Influenza in the COVID-19 era. JAMA 324:1342–1343</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.14661</ArticleId><ArticleId IdType="pubmed">32797145</ArticleId></ArticleIdList></Reference><Reference><Citation>Yılmaz K, Şen V, Aktar F et al (2021) Does Covid-19 in children have a milder course than Influenza? Int J Clin Pract 75(9): e 14466</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention, National Center for Immunization an Respiratory Diseases (NCIRD) (2023) U.S. Influenza Sruveillance: Purpose and Methods. https://www.cdc.gov/flu/weekly/overview.htm . Last Reviewed 13 October 2023</Citation></Reference><Reference><Citation>Cowling BJ, Chan KH, Fank VJ et al (2020) Comparative epidemiology of pandemic and Seasonal Influenza A in households. N Engl J Med 362:2175–2184</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0911530</ArticleId></ArticleIdList></Reference><Reference><Citation>American Academy of Pediatrics (2024) Coronavirus Disease 2019 (COVID-19). In: Kimberlin DW, Banerjee R, Banett ED, Lynfield R, Sawyer MH, eds. Red Book: 2024 Report of the Committee On Infectious Diseases. American Academy of Pediatrics 324–332</Citation></Reference><Reference><Citation>Dawood FS, Rao S (2023) Influenza Viruses. In: Long SS, Prober CG, Fischer M, Kimberlin DW (ed). Principles and Practice of Pediatric Infectious Diseases, 6th ed. Philadelphia, PA 19103 – 2899, by Elsevier, Inc 229, pp. 1205–1213.e5</Citation></Reference><Reference><Citation>World Health Organization (WHO) (2020) COVID-19 case definition: Updated in Public health surveillance for COVID-19. WHO/2019-nCoV/Surveillance_Case_Definition/2020.2. Accessed 16 December 2020</Citation></Reference><Reference><Citation>Liu X, Li W, Zhang B et al (2021) Comparative study of hospitalized children with acute respiratory distress syndrome caused by SARS-CoV-2 and influenza virus. BMC Infect Dis 21:412–421</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06068-w</ArticleId><ArticleId IdType="pubmed">33947345</ArticleId><ArticleId IdType="pmc">8093914</ArticleId></ArticleIdList></Reference><Reference><Citation>Laris-González A, Avilés-Robles M, Domínguez-Barrera C et al (2021) Influenza vs. COVID-19: comparison of clinical characteristics and outcomes in Pediatric patients in Mexico City. Front Pediatr 9:676611</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.676611</ArticleId><ArticleId IdType="pubmed">34249813</ArticleId><ArticleId IdType="pmc">8264261</ArticleId></ArticleIdList></Reference><Reference><Citation>Flerlage T, Boyd DF, Meliopoulos V et al (2021) Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract. Nat Rev Microbiol 19:425–441</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00542-7</ArticleId><ArticleId IdType="pubmed">33824495</ArticleId><ArticleId IdType="pmc">8023351</ArticleId></ArticleIdList></Reference><Reference><Citation>Osman M, Klopfenstein T, Belfeki N et al (2021) A comparative systematic review of COVID-19 and Influenza. Viruses 13:452–464</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13030452</ArticleId><ArticleId IdType="pubmed">33802155</ArticleId><ArticleId IdType="pmc">8001286</ArticleId></ArticleIdList></Reference><Reference><Citation>Asseri AA, Shati AA, Al-Qahtani SM et al (2021) Distinctive clinical and laboratory features of COVID-19 and H1N1 influenza infections among hospitalized pediatric patients. World J Pediatr 17:272–279</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-021-00432-1</ArticleId><ArticleId IdType="pubmed">33970449</ArticleId><ArticleId IdType="pmc">8108014</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Y, Tao X (2021) Comparison of COVID-19 and influenza characteristics. J Zhejiang Univ Sci B 22:87–98</Citation><ArticleIdList><ArticleId IdType="doi">10.1631/jzus.B2000479</ArticleId><ArticleId IdType="pubmed">33615750</ArticleId><ArticleId IdType="pmc">7885750</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Q, Fang X, Pang Z et al (2020) COVID-19 and cutaneous manifestations: a systematic review. J Eur Acad Dermatol Venereol 34:2505–2510</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdv.16778</ArticleId><ArticleId IdType="pubmed">32594572</ArticleId><ArticleId IdType="pmc">7361780</ArticleId></ArticleIdList></Reference><Reference><Citation>Behzad S, Aghaghazvini L, Radmard AR et al (2020) Extrapulmonary manifestations of COVID-19: radiologic and clinical overview. Clin Imaging 66:35–41</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinimag.2020.05.013</ArticleId><ArticleId IdType="pubmed">32425338</ArticleId><ArticleId IdType="pmc">7233216</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu BM, Hill HR (2020) Role of host Immune and inflammatory responses in COVID-19 cases with underlying primary immunodeficiency: a review. J Interferon Cytokine Res 40(12):549–554</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jir.2020.0210</ArticleId><ArticleId IdType="pubmed">33337932</ArticleId><ArticleId IdType="pmc">7757688</ArticleId></ArticleIdList></Reference><Reference><Citation>LeMessurier KS, Rooney R, Ghoneim HE et al (2020) Influenza a virus directly modulates mouse eosinophil responses. J Leukoc Biol 108(1):151–168</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.4MA0320-343R</ArticleId><ArticleId IdType="pubmed">32386457</ArticleId></ArticleIdList></Reference><Reference><Citation>Pormohammad A, Ghorbani S, Khatami A et al (2020) Comparison of influenza type A and B with COVID-19: a global systematic review and meta‐analysis on clinical, laboratory and radiographic findings. Rev Med Virol 31(3):e2179</Citation></Reference><Reference><Citation>Piroth L, Cottenet J, Mariet AS et al (2021) Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study. Lancet Respir Med 9:251–259</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30527-0</ArticleId><ArticleId IdType="pubmed">33341155</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao YD, Ding M, Dong X et al (2021) Risk factors for severe and critically ill COVID-19 patients: a review. Allergy 76:428–455</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14657</ArticleId><ArticleId IdType="pubmed">33185910</ArticleId></ArticleIdList></Reference><Reference><Citation>Graff K, Smith C, Silveira L et al (2021) Risk factors for severe COVID-19 in children. Pediatr Infect Dis J 40:e137–e145</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003043</ArticleId><ArticleId IdType="pubmed">33538539</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang AJ, Lee ACY, Chan JFW et al (2021) Coinfection by severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 virus enhances the severity of Pneumonia in Golden Syrian hamsters. Clin Infect Dis 72:e978–e992</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1747</ArticleId><ArticleId IdType="pubmed">33216851</ArticleId></ArticleIdList></Reference><Reference><Citation>Covin S, Rutherford GW (2021) Co-infection, SARS-CoV-2 and influenza: an evolving puzzle. Clin Infect Dis 72:e993–e994</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1810</ArticleId><ArticleId IdType="pubmed">33277660</ArticleId></ArticleIdList></Reference><Reference><Citation>Dao TL, Hoang VT, Colson P et al (2021) Co-infection of SARS-CoV-2 and influenza viruses: a systematic review and meta-analysis. J Clin Virol Plus 1(3):100036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcvp.2021.100036</ArticleId><ArticleId IdType="pubmed">35262019</ArticleId><ArticleId IdType="pmc">8349735</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma S, Lai X, Chen Z et al (2020) Clinical characteristics of critically ill patients co-infected with SARS-CoV-2 and the influenza virus in Wuhan, China. Int J Infect Dis 96:683–687</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.05.068</ArticleId><ArticleId IdType="pubmed">32470606</ArticleId><ArticleId IdType="pmc">7250072</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue H, Zhang M, Xing L et al (2020) The epidemiology and clinical characteristics of co-infection of SARS-CoV-2 and influenza viruses in patients during COVID-19 outbreak. J Med Virol 92(11):2870–2873</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26163</ArticleId><ArticleId IdType="pubmed">32530499</ArticleId><ArticleId IdType="pmc">7307028</ArticleId></ArticleIdList></Reference><Reference><Citation>Stowe J, Tessier E, Zhao H et al (2021) Int J Epidemiol 50(4):1124–1133</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyab081</ArticleId><ArticleId IdType="pubmed">33942104</ArticleId><ArticleId IdType="pmc">8135706</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B (2016) Universal PCR primers are critical for direct sequencing-based enterovirus genotyping. J Clin Microbiol 28(1):339–340</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01801-16</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B, Forman M, Valsamakis A (2019) Optimization and evaluation of a novel real-time RT-PCR test for detection of parechovirus in cerebrospinal fluid. J Virol Methods 272:113690</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2019.113690</ArticleId><ArticleId IdType="pubmed">31283959</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B, Totten M, Nematollahi S et al (2020) Development and evaluation of a fully automated Molecular Assay Targeting the mitochondrial small subunit rRNA gene for the detection of Pneumocystis Jirovecii in Bronchoalveolar Lavage fluid specimens. J Mol Diagn 22(12):1482–1493</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmoldx.2020.10.003</ArticleId><ArticleId IdType="pubmed">33069878</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato Y, Nirasawa S, Saeki M et al (2022) Comparative study of rapid antigen testing and two nucleic acid amplification tests for influenza virus detection. J Infect Chemother 28(7):1033–1036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiac.2022.04.009</ArticleId><ArticleId IdType="pubmed">35428574</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>